Researching rare and ultra-rare diseases sometimes means taking the study to the patients, setting up sites in countries unaccustomed to hosting clinical research. Premier Research will examines the  challenges of conducting trials in such unconventional locales in this webinar.

Opening sites in countries where trials are uncommon and not thoroughly regulated requires that sponsors really understand the host country and conduct thorough training in protocol and good clinical practices. Alison Sampson, Senior Project Director, and Hanna Wide, Project Manager, cover these and other topics during Rare Disease Research: Conducting Clinical Trials Where the Patients Are

Watch today to learn the importance of qualifying patients before opening study sites, and how careful monitoring and oversight will minimize protocol deviations and ensure data integrity. Other topics will include:

About Premier Research

Premier Research is a leading contract research organization serving the needs of biotechnology, pharmaceutical, and medical device companies worldwide. The company has a wealth of experience in the execution of global, regional, and local clinical development programs, with a special focus on addressing unmet needs in such areas as analgesia, CNS, rare diseases, medical device and diagnostics, and pediatric research. Premier Research operates in 84 countries and employs more than 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. With its mission to improve productivity in clinical development, the company aligns itself with the mission of its customers to bring new medical treatments to patients promptly, accurately, and cost-effectively.